Apollo Medical Hlds

Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q3 2024

Apollo Medical Hlds reports robust 2022 performance and optimistic 2023 guidance

Apollo Medical Hlds delivered a strong financial performance in Q4 2022 and achieved record revenue for 2022, supported by membership growth and operational initiatives.
The company's focus on enhancing patient care through technology integration and strategic acquisitions positions it well for future growth.
While facing challenges in managing operational expenses, Apollo Medical Hlds has opportunities to drive innovation and expand its market presence in 2023.
Overall, Apollo Medical Hlds remains well-positioned with a solid financial foundation and a clear growth trajectory for the upcoming year.

Apollo Medical Hlds reports robust Q1 performance and growth opportunities

Apollo Medical Hlds showcased strong financial performance and operational goals for Q1 2023, despite challenges like unsuccessful contract renewals.
Membership growth, controlled medical loss ratios, and financial stability are key strengths for the company.
Opportunities in expanding membership, transitioning to risk contracts, and reaching Medicare member targets are on the horizon.

ApolloMed reports robust Q2 earnings, eyes growth through partnerships

Apollo Medical Hlds (AMEH) delivered a strong performance in Q2 2023, with notable revenue and EBITDA growth driven by membership expansion and strategic initiatives.
Despite facing challenges related to tax restatements and market uncertainties, the company remains well-positioned with a solid cash reserve and growth prospects.
With a focus on partnerships, acquisitions, and operational efficiency, ApolloMed is poised to capitalize on growth opportunities and enhance shareholder value.

Apollo Medical Holdings excels in Q3, eyes strategic growth

Apollo Medical Holdings demonstrated strong financial performance and strategic growth initiatives in Q3 2023, positioning them for continued success.
While facing challenges such as Medicaid redetermination and market dynamics, the company's focus on partnerships and financial management remains strong.
Opportunities for growth lie in expanding service offerings, geographic reach, and enhancing patient care through innovative partnerships.
Overall, ApolloMed's financial outlook, acquisitions, and partnerships indicate a positive trajectory for future growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.

ALHAMBRA, Calif. , Sept. 26, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it and its affiliated California medical corporation have entered into a definitive agreement to acquire 100% of the fully diluted capitalization of All American Medical Group ("AAMG") and For Your Benefit, Inc. ("FYB"), as well as certain related managed care assets.

Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire All American Medical Group and For Your Benefit

ALHAMBRA, Calif. , Sept. 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that management will be presenting at the following virtual investor conferences: Bank of America Healthcare Innovation Forum Date: Thursday, September 29, 2022 Barclays Value Based Care Investor Conference Date: Thursday, October 6, 2022 Management will also be participating in virtual one-on-one meetings at these events.

Apollo Medical Holdings, Inc. to Participate in Upcoming Virtual Investor Conferences

Apollo Medical Holdings, Inc. (NASDAQ:AMEH ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Carolyne Sohn – Investor Relations Brandon Sim – Co-Chief Executive Officer Chan Basho – Chief Strategy Officer and Interim Chief Financial Officer Conference Call Participants Operator Good day. And welcome to your Apollo Medical Holdings' Second Quarter 2022 Financial Results Call.

Apollo Medical Holdings, Inc. (AMEH) Management Team on Q2 2022 Results - Earnings Call Transcript

Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET ALHAMBRA, Calif.

Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results

ALHAMBRA, Calif. , July 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter and six months ended June 30, 2022, after the close of the stock market on Thursday, August 4, 2022.

Apollo Medical Holdings, Inc. Schedules 2022 Second Quarter Financial Results Release and Conference Call

Apollo Medical Holdings (NASDAQ: AMEH), a market-leading physician-centric healthcare management company, has recently seen a lot of insider buying. Namely,.

ApolloMed sees $9 million in insider buying; AMEH stock jumps over 6%

ALHAMBRA, Calif. , May 11, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that Brandon Sim, Co-Chief Executive Officer, is scheduled to present at the following events in New York: 2022 RBC Capital Markets Global Healthcare Conference Date: Wednesday, May 18, 2022, at 11:35 a.m.

Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences

Apollo Medical Holdings, Inc. (NASDAQ:AMEH ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Carolyne Sohn – Investor Relations Brandon Sim – Co-Chief Executive Officer Eric Chin – Chief Financial Officer Chan Basho – Chief Strategy Officer & Interim Chief Financial Officer Conference Call Participants Operator Greetings. Welcome to the Apollo Medical Holdings First Quarter 2022 Financial Results.

Apollo Medical Holdings, Inc. (AMEH) CEO Brandon Sim on Q1 2022 Results - Earnings Call Transcript

ALHAMBRA, Calif., May 5, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced the appointment of Chan Basho to the newly created role of Chief Strategy Officer.

Apollo Medical Holdings, Inc. Announces Appointment of Chief Strategy Officer and CFO Transition

Apollo Medical Holdings, Inc. Reports First Quarter 2022 Results

ALHAMBRA, Calif. , April 28, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the first quarter ended March 31, 2022, after the close of the stock market on Thursday, May 5, 2022.

Apollo Medical Holdings, Inc. Schedules 2022 First Quarter Financial Results Release and Conference Call

Apollo Medical Holdings is a healthcare tech company operating in a fast-growing industry.

Apollo Medical: A Novel HealthTech Company Leading The Digital Revolution

Apollo Medical Holdings, Inc. (AMEH) Brandon Sim on Q4 2021 Results - Earnings Call Transcript

ALHAMBRA, Calif., Feb. 24, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2021.

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results

ALHAMBRA, Calif., Feb. 10, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021, after the close of the stock market on Thursday, February 24, 2022.

Apollo Medical Holdings, Inc. Schedules 2021 Fourth Quarter and Year-end Financial Results Release and Conference Call

AMN Healthcare Services

ArcBest

United Microelectronics

Universal Technical Institute

ARCB, UMC, UTI, AMN, and AMEH have been added to the Zacks Rank #1 (Strong Buy) List on February 4, 2022.

New Strong Buy Stocks for February 4th

ALHAMBRA, Calif. , Jan. 27, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it has acquired 100% of the fully diluted capitalization of Orma Health, Inc., and Provider Growth Solutions LLC (together, "Orma Health") in accordance with an agreement between ApolloMed, Orma Health and certain equity holders of Orma Health.

Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health, Welcomes New Chief Analytics Officer and President of Provider Solutions

LifeMD 

The Zacks Medical - Services industry is growing on digital healthcare adoption. AMN, AMEH and LFMD are set to gain the most.

3 Medical Services Stocks to Buy Despite Near-Term Industry Woes

LOS ANGELES--(BUSINESS WIRE)---- $AMEH #BestCompanies2021--Investor's Business Daily (IBD), a leading financial news and research organization, today announced its list of the 100 Best Companies of 2021. Companies were selected based on stock performance throughout the year as the economy recovered from COVID-19's initial jolt. GameStop claimed the top spot on the 2021 list, up 687.63% over 2020. The listmakers came from diverse sectors: biotech, “meme” stocks and medical companies featured prominently on this year's list,

IBD Reveals the 100 Best Companies of 2021

ModivCare

MODV vs. AMEH: Which Stock Is the Better Value Option?

LOS ANGELES--(BUSINESS WIRE)--Society 1, an exclusive membership club, has been making waves lately by supporting and gaining the backing of notable Asian American-led enterprises. Most recently, Society 1 welcomed ApolloMed to their prestigious list of corporate members. ApolloMed, led by two Asian American Co-CEOs, hosted employees, partners, and valued guests for their annual festivities celebrating diversity, equity, and inclusion in healthcare at the JW Marriott Hotel in Downtown Los Angel

Society 1 and ApolloMed Stand in Solidarity for the AAPI Community at Holiday Broadway Concert

ALHAMBRA, Calif., Jan. 4, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that Brandon Sim, Co-Chief Executive Officer, is scheduled to present virtually at the 40th Annual J.P.

Apollo Medical Holdings, Inc. to Present at 40th Annual J.P. Morgan Healthcare Conference

ALHAMBRA, Calif., Dec. 21, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, announced today that its affiliate, AP-AMH 2 Medical Corporation, has entered into a definitive agreement to acquire 100% of the fully diluted capitalization of Jade Health Care Medical Group ("Jade Health"), a primary and specialty care physicians' group focused on providing high-quality care to its local communities.

Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire Jade Health Care Medical Group

ALHAMBRA, Calif., Dec. 20, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced the appointments of Weili Dai, a renowned entrepreneur, technology executive and philanthropist, and J.

News for Apollo Medical Hlds Stock (AMEH)